Our study also proposes the activation of LAG3, for weakening the differentiation of Treg cells, which may account for insufficient Treg cells in NOD mice or patients with T1D with elevated circulating Galectin-3 levels. The gene discussed is LAG3; the disease is type 1 diabetes mellitus.